4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-26-000056
Chief Accounting Officer acquired 62,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lerner Neil Chief Accounting Officer | 2026-01-02 | Grant or award | +62,500 | $5.17 | $323,125 | 382,500 | D |
| Derivatives | |||||||
| Lerner Neil Chief Accounting Officer | 2026-01-02 | Grant or award · Stock Option (Right to Buy) | +435,000 | 435,000 | D | ||
Loading xslF345X05/ownership.xml…